Position dérivée des transactions déclarées les plus récentes. Non ajustée des splits ni des conversions de classes d'actions.
| Émetteur | Actions | Source | Dernière tx | Détail |
|---|---|---|---|---|
| AVANIR PHARMACEUTICALS | 8 904 746 | déclaré | 11 août 2009 | tx 8+791 477−894 120 |
| EAGLE PHARMACEUTICALS, INC. | 3 779 287 | déclaré | 20 mars 2017 | tx 34+4 838 798−4 719 498 |
| CADENCE PHARMACEUTICALS INC | 2 895 282 | déclaré | 19 sept. 2007 | tx 86+3 053 174−12 384 298 |
| Immune Design Corp. | 2 290 177 | déclaré | 16 avr. 2015 | tx 7−183 256 |
| OPTIMER PHARMACEUTICALS INC | 10 000 | déclaré | 08 janv. 2010 | tx 28+2 844 558−1 179 463 |
| NOVADEL PHARMA INC | 0 | déclaré | 31 déc. 2009 | tx 4+23 237 083−13 034 481 |
| Date | Type | Émetteur | Quantité | Prix | Signaux |
|---|---|---|---|---|---|
| 17 mars 2017 | SALE | EAGLE PHARMACEUTICALS, INC. | 38 997 | 82.01 USD | |
| 16 mars 2017 | SALE | EAGLE PHARMACEUTICALS, INC. | 9 120 | 82.08 USD | |
| 20 mars 2017 | SALE | EAGLE PHARMACEUTICALS, INC. | 51 883 | 82.10 USD | |
| 06 sept. 2016 | SALE | EAGLE PHARMACEUTICALS, INC. | 12 958 | 62.45 USD | |
| 06 sept. 2016 | SALE | EAGLE PHARMACEUTICALS, INC. | 12 224 | 63.25 USD | |
| 06 sept. 2016 | SALE | EAGLE PHARMACEUTICALS, INC. | 49 | 62.83 USD | |
| 06 sept. 2016 | SALE | EAGLE PHARMACEUTICALS, INC. | 166 | 62.83 USD | |
| 07 sept. 2016 | SALE | EAGLE PHARMACEUTICALS, INC. | 11 345 | 62.26 USD | |
| 07 sept. 2016 | SALE | EAGLE PHARMACEUTICALS, INC. | 22 | 62.26 USD | |
| 07 sept. 2016 | SALE | EAGLE PHARMACEUTICALS, INC. | 75 | 62.26 USD | |
| 08 sept. 2016 | SALE | EAGLE PHARMACEUTICALS, INC. | 33 796 | 62.33 USD | |
| 08 sept. 2016 | SALE | EAGLE PHARMACEUTICALS, INC. | 66 | 62.33 USD | |
| 08 sept. 2016 | SALE | EAGLE PHARMACEUTICALS, INC. | 224 | 62.33 USD | |
| 04 janv. 2016 | GRANT_AWARD | EAGLE PHARMACEUTICALS, INC. | 15 000 | 0.00 USD | deriv |
| 21 avr. 2015 | GRANT_AWARD | EAGLE PHARMACEUTICALS, INC. | 10 000 | 0.00 USD | deriv |
| 14 avr. 2015 | SALE | Immune Design Corp. | 13 814 | 27.26 USD | |
| 16 avr. 2015 | SALE | Immune Design Corp. | 100 | 26.75 USD | |
| 15 avr. 2015 | SALE | Immune Design Corp. | 100 | 29.17 USD | |
| 15 avr. 2015 | SALE | Immune Design Corp. | 39 900 | 28.57 USD | |
| 13 mars 2015 | GRANT_AWARD | EAGLE PHARMACEUTICALS, INC. | 5 000 | 0.00 USD | deriv |
| 12 mars 2015 | SALE | Immune Design Corp. | 94 199 | 24.94 USD | |
| 10 mars 2015 | SALE | Immune Design Corp. | 6 143 | 24.65 USD | |
| 11 mars 2015 | SALE | Immune Design Corp. | 29 000 | 25.02 USD | |
| 08 avr. 2014 | GRANT_AWARD | EAGLE PHARMACEUTICALS, INC. | 4 680 | 0.00 USD | deriv |
| 18 févr. 2014 | CONVERSION | EAGLE PHARMACEUTICALS, INC. | 1 927 986 | — |
1 achat déclaré après au moins 12 mois de silence — dernière occurrence le 18 févr. 2014.